Insights Directory
-
Nuclear Energy and Other Renewables (Sustainability Part 2 of 2): A Conversation with George Gianarikas, CG's Sustainability Senior Analyst
George Gianarikas, CG's Sustainability Senior Analyst, returns to the podcast with Michael Graham, Director of Research and Investment Strategy, to discuss the energy market from the recent acceleration in demand to the companies that can help get us to meet it.
Sustainability
-
Taking the Pulse of Digital Assets: A Conversation with Joseph Vafi, CFA, CG’s Senior FinTech and Digital Assets Analyst
Joseph Vafi, CFA, CG’s Senior Fintech and Digital Assets Analyst returns to the podcast with Michael Graham, Director of Research and Investment Strategy, following significant IPOs and policy updates in his space.
Technology
-
Software Quarterly Update - Q2 2025
Technology
-
Vehicles and Autonomous Driving (Sustainability Part 1 of 2): A Conversation with George Gianarikas, CG's Sustainability Senior Analyst
George Gianarikas, CG's Sustainability Senior Analyst, joins Michael Graham, Director of Research and Investment Strategy, to discuss the latest developments, challenges and opportunities for the EV and autonomous driving markets.
Sustainability
-
Cyber Security Quarterly Update - Q2 2025
CG's Cyber Security Update for Q2 2025 provides an update on the current market landscape including valuation trends, and recent public and private transaction activity.
Technology
-
NewSpace, Business in the Final Frontier: A Conversation with Austin Moeller, CG’s Aerospace and Defense Technology Analyst
Austin Moeller, CG’s Senior Aerospace and Defense Technology Analyst, joins Michael Graham, Director of Research and Investment strategy to discuss the topical ideas in the space and travel markets.
Industrials/Aerospace & Defense
-
M&A Environment Report - Q2 2025
Consumer and Retail
Healthcare
Sustainability
Technology
-
Sustainability Dashboard - May 2025
Sustainability
-
Navigating Nervous Times - The Risks, Rewards, and Complexities of Neurological Indications: A Conversation with Sumant Kulkarni CG’s Biotechnology Senior Analyst
Sumant Kulkarni, CG’s Senior Analyst covering Biotechnology with a focus on neuroscience joins Director of Research and Investment Strategy Michael Graham, CFA to discuss the intricacies of indications in his space, the ever-present opportunities and how drug research and development have evolved over time. Listen here:
Healthcare